Maintenance Treatment With Avastin and Tarceva in Combination Helps Lung...
Basel, Switzerland (ots/PRNewswire) – - For ex-US Media Only - Phase III ATLAS Study Achieves a New Milestone in Treating Advanced Lung Cancer Roche announced today that the Phase III ATLAS study...
View ArticleGlobal Phase III Trial With Selective c-MET Inhibitor Tivantinib (ARQ 197)...
Munich (ots/PRNewswire) – Daiichi Sankyo announced today that it has begun enrolling patients in Europe into a large, multinational phase III trial of tivantinib (ARQ 197). Tivantinib is an...
View ArticleLyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in...
Paris (ots/PRNewswire) – - First once-daily prandial GLP-1 receptor agonist offering a new treatment option for Japanese people living with type 2 diabetes – Sanofi announced today that Japan’s...
View ArticleData Show Sanofi’s Lyxumia® Added to Basal Insulin Lowered Blood Sugar...
Paris (ots/PRNewswire) – - Findings Consistent with Known Post-Prandial Effect of Lyxumia Supporting Combination with Basal Insulin – Sanofi announced today new GetGoal-L sub-analysis results showing...
View Article
